· Execute the ICE field execution framework by:
•
•
segmenting customers according to company standards (e.g., via ViP tool),
•
applying value-based tiering,
•
using tailored promotional content and key messages by segment audience,
•
adhering to data driven call plans suggestions (e.g., via IDS+),
•
consistently deploying personalized omnichannel customer journeys enabled by global International digital tools (e.g., RepAI, IDS+, OnCore,Veeva, etc.),
•
timely documenting customers visits.
· Deliver high-quality, compliant product promotion in-field activities and customer engagements, in alignment with brand and TA strategies and by:
•
•
applying approved messages through the 6 Impact Behaviors (6IBs) selling model,
•
leveraging technology enablement to enhance customer engagement (e.g. RepAI, IDS+, OnCore, Veeva, CRM, etc.),
•
continuously improving execution quality through building on coaching feedback inputs, field effectiveness assessment reports (STEM) and performance insights (e.g. BEST, C360, etc.) with respective TA head.
· Act as a trusted therapeutic area commercial partner to HCPs, explaining clinical data, evidence, and appropriate product use.
· Maximize technology enablement support systems, e.g. “next best action” proposals, to enhance customer engagement impact.
· Collect, interpret, and share field insights on best practices, customer needs, market dynamics, competitor activity, and territory needs and priorities, to develop actions to address them.
· Participate in or contribute to local events, meetings, and promotional activities in compliance with governance standards.
· Collaborate cross-functionally with TA Marketing, Medical TA, Value & Access, and Execution Excellence partners.
· Operate fully in line with Novartis policies, ethical standards, and local regulatory requirements.